Hahn, F.; Häge, S.; Herrmann, A.; Wangen, C.; Kicuntod, J.; Jungnickl, D.; Tillmanns, J.; Müller, R.; Fraedrich, K.; Überla, K.;
et al. Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2. Pathogens 2021, 10, 1076.
https://doi.org/10.3390/pathogens10091076
AMA Style
Hahn F, Häge S, Herrmann A, Wangen C, Kicuntod J, Jungnickl D, Tillmanns J, Müller R, Fraedrich K, Überla K,
et al. Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2. Pathogens. 2021; 10(9):1076.
https://doi.org/10.3390/pathogens10091076
Chicago/Turabian Style
Hahn, Friedrich, Sigrun Häge, Alexandra Herrmann, Christina Wangen, Jintawee Kicuntod, Doris Jungnickl, Julia Tillmanns, Regina Müller, Kirsten Fraedrich, Klaus Überla,
and et al. 2021. "Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2" Pathogens 10, no. 9: 1076.
https://doi.org/10.3390/pathogens10091076
APA Style
Hahn, F., Häge, S., Herrmann, A., Wangen, C., Kicuntod, J., Jungnickl, D., Tillmanns, J., Müller, R., Fraedrich, K., Überla, K., Kohlhof, H., Ensser, A., & Marschall, M.
(2021). Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2. Pathogens, 10(9), 1076.
https://doi.org/10.3390/pathogens10091076